Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PZ-2891 is a modulator of pantothenate kinase (PanK).1 It selectively inhibits PanK1β, PanK2, and PanK3 (IC50s = 40.2, 0.7, and 1.3 nM, respectively) in the absence of acetyl-CoA over 468 other kinases and a panel of 72 receptors and ion channels at 10 µM. PZ-2891 (2.5 µM) reverses acetyl-CoA-induced inhibition of PanK3 in a cell-free assay, indicating activation of PanK3 activity. It increases intracellular CoA levels in wild-type PanK3-expressing HEK293T cells, but not in HEK293T cells expressing the catalytically inactive mutant PanK3E138A. PZ-2891 increases survival in a mouse model of neuronal CoA deficiency induced by brain knockout of Pank1 and Pank2. It prevents infection of mosquitoes (A. stephensi) by P. falciparum.2
WARNING This product is not for human or veterinary use.
1. A therapeutic approach to pantothenate kinase associated neurodegeneration. Nat. Commun. 9(1), (2018).
2. Activation of Anopheles stephensi pantothenate kinase and coenzyme A biosynthesis reduces infection with diverse Plasmodium species in the mosquito host. Biomolecules 11(6), 807 (2021).